GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
DHANIKULA, Anand Babu,MCQUEEN, Lisa
申请号：
IBIB2019/060437
公开号：
WO2020/115676A1
申请日:
2019.12.04
申请国别(地区):
IB
年份:
2020
代理人:
摘要：
Disclosed are novel pharmaceutical formulations comprising (E)-1-(4-(5-Carbamoyl-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-(3-morpholinopropoxy)-1H-benzo[d]imidazol-1-yl)but-2-en-1-yl)-2-(1-ethyl-3-methyl-1H-pyrazole-5-carboxamido)-7-methoxy-1H-benzo[d]imidazole-5-carboxamide, processes for preparing the same, and methods of using the same.La présente invention concerne de nouvelles formulations pharmaceutiques comprenant le (E)-1-(4-(5-carbamoyl-2-(1-éthyl-3-méthyl-1H-pyrazole-5-carboxamido)-7-(3-morpholinopropoxy)-1H-benzo[d]imidazol-1-yl)but-2-én-1-yl)-2-(1-éthyl-3-méthyl-1H-pyrazole-5-carboxamido)-7-méthoxy-1H-benzo[d]imidazole-5-carboxamide, leurs procédés de préparation et leurs méthodes d'utilisation.
